WSW, NY, 9th February 2026, FinanceWire … Read More
VOO
Actelis Networks Appears to Be Gaining Momentum in 2026 as Infrastructure Orders Stack Up (NASDAQ: ASNS)
WSW, NY, 2nd February 2026, FinanceWire … Read More
MediWound’s EscharEx: A Late-Stage Asset Built for a Re-Normalized Wound Care Market (NASDAQ: MDWD)
WSW, NY, 29th January 2026, FinanceWire … Read More
Purple Biotech’s “Capping” Technology Enables 300× Higher Dosing in Cancer Immunotherapy (NASDAQ: PPBT)
WSW, NY, 20th January 2026, FinanceWire … Read More
Actelis Networks Is Tapping Into a Growing Wave of Smart City Infrastructure Investment (NASDAQ: ASNS)
WSW, NY, 19th January 2026, FinanceWire … Read More
Palatin Technologies Targets Hypothalamic Obesity as Next Frontier Beyond GLP-1s (NYSE: PTN)
WSW, NY, 12th January 2026, FinanceWire … Read More
MediWound’s Enzymatic Burn Therapy Deployed After New Year’s Tragedy in Switzerland (NASDAQ: MDWD)
WSW, NY, 2nd January 2026, FinanceWire … Read More
Actelis Networks is Helping America Modernize its Aging Infrastructure, While Chinese Hackers Continue to Target It (NASDAQ: ASNS)
WSW, NY, 29th December 2025, FinanceWire … Read More
Nasus Pharma Receives $19 Price Target and ‘Market Outperform’ Rating From Citizens Analyst
WSW, NY, 18th December 2025, FinanceWire … Read More
Nuvectis Pharma’s New Phase 1b Trial Targets a Major Lung Cancer Bottleneck (NASDAQ: NVCT)
WSW, NY, 17th December 2025, FinanceWire … Read More